ZANELLO, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 3.038
EU - Europa 2.079
AS - Asia 1.089
AF - Africa 142
SA - Sud America 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.356
Nazione #
US - Stati Uniti d'America 3.024
GB - Regno Unito 490
DE - Germania 422
CN - Cina 362
VN - Vietnam 308
SG - Singapore 270
IT - Italia 254
SE - Svezia 253
UA - Ucraina 156
FI - Finlandia 119
RU - Federazione Russa 105
IN - India 93
FR - Francia 82
IE - Irlanda 80
TG - Togo 46
CI - Costa d'Avorio 40
EE - Estonia 36
ZA - Sudafrica 30
BG - Bulgaria 23
CH - Svizzera 20
JO - Giordania 17
BE - Belgio 13
CA - Canada 13
IR - Iran 13
SC - Seychelles 12
NG - Nigeria 11
ES - Italia 7
JP - Giappone 7
AT - Austria 4
UZ - Uzbekistan 4
AU - Australia 3
CZ - Repubblica Ceca 3
NL - Olanda 3
TR - Turchia 3
ET - Etiopia 2
HR - Croazia 2
ID - Indonesia 2
IL - Israele 2
IQ - Iraq 2
LB - Libano 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
LT - Lituania 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
Totale 6.356
Città #
Southend 442
Fairfield 413
Chandler 338
Ashburn 237
Singapore 223
Dong Ket 202
Munich 184
Woodbridge 179
Seattle 168
Wilmington 163
Houston 158
Santa Clara 140
Cambridge 132
Helsinki 109
Princeton 108
Jacksonville 105
Ann Arbor 97
Dublin 80
Boardman 64
Nanjing 54
Westminster 47
Lomé 46
Bologna 44
Padova 43
Abidjan 40
Berlin 34
San Diego 31
Dearborn 29
Jinan 27
Saint Petersburg 24
Sofia 23
New York 22
Falkenstein 19
Milan 19
Turin 19
Des Moines 18
Amman 17
Bern 17
Florence 17
Los Angeles 17
Mülheim 16
Shenyang 15
Nanchang 14
Shanghai 14
Beijing 13
Brussels 13
Mahé 12
Guangzhou 11
Hebei 11
Mountain View 11
Redwood City 11
Tianjin 11
Abeokuta 10
Yubileyny 10
Olalla 9
Changsha 8
Toronto 8
Verona 8
Jyväskylä 7
Monmouth Junction 7
Ningbo 7
Tokyo 7
Zhengzhou 7
Falls Church 6
Jiaxing 6
London 6
Redmond 6
Borello 5
Haikou 5
Leawood 5
Madrid 5
Norwalk 5
Qingdao 5
Rome 5
Bühl 4
Chongqing 4
Edinburgh 4
Frankfurt am Main 4
Fremont 4
Fuzhou 4
Lanzhou 4
Medford 4
Taizhou 4
Zanjan 4
Ardabil 3
Baoding 3
Catania 3
Chengdu 3
Hangzhou 3
Hefei 3
Kunming 3
Paris 3
Phoenix 3
Plauen 3
San Venanzo 3
Vienna 3
Addis Ababa 2
Augusta 2
Casalecchio di Reno 2
Cesena 2
Totale 4.532
Nome #
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 287
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 237
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 195
A new liver transplant priority for patients with hepatocellular carcinoma. 189
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 183
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis b-and c-related-hepatocellularcarcinoma 182
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 176
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 161
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 157
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 153
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 153
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 145
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 144
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 143
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 142
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 141
Using Elderly Donors in Liver Transplantation. 138
Matricellular proteins and survival in patients with pancreatic cancer: A systematic review 138
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 136
Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review 133
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 132
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 127
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 125
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation. 124
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 119
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. 119
The role of liver resections for metastases from lung carcinoma. 116
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 116
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 115
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 115
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 107
The role of liver resections for metastases from lung carcinoma 105
Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. 104
Sirolimus in liver transplant recipients: a large single-center experience. 104
Hepatitis B virus and hepatitis C virus infections and risk of pancreatic ductal adenocarcinoma 102
The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. 101
Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: the university of bologna experience over 10 years. 101
Prospective down-staging protocol for HCC not meeting the Milan criteria 96
Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. 95
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? 95
Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation. 94
Nested stromal-epithelial tumor (NSET) of the liver: A case report of an extremely rare tumor. 92
Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy 89
The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer 85
Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience 78
Use of vascular clamping in hepatic surgery: lessons learned from 1260 liver resections. 76
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 74
Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC 73
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 72
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 41
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 39
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery 38
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 28
Correction: Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry (Surgical Endoscopy, (2023), 10.1007/s00464-023-09937-4) 26
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario 12
Totale 6.468
Categoria #
all - tutte 17.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020210 0 0 0 0 0 0 0 0 0 89 37 84
2020/2021828 137 81 27 28 16 38 21 49 50 35 46 300
2021/20221.005 105 43 58 76 88 52 19 68 29 43 256 168
2022/20231.220 110 198 64 167 59 103 31 89 223 24 99 53
2023/2024308 25 58 15 34 32 54 20 20 6 14 16 14
2024/20251.161 48 182 91 162 205 129 170 105 68 1 0 0
Totale 6.468